Correlation Between Reviva Pharmaceuticals and Quantum Si

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Quantum Si at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Quantum Si into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Quantum Si incorporated, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Quantum Si and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Quantum Si. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Quantum Si.

Diversification Opportunities for Reviva Pharmaceuticals and Quantum Si

0.42

Correlation Coefficient

Reviva Pharmaceuticals  Quantum Si

Very weak diversification

The 3 months correlation between Reviva and Quantum is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Quantum Si incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Si incorporated and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Quantum Si. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Si incorporated has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Quantum Si go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Quantum Si

Assuming the 90 days horizon Reviva Pharmaceuticals is expected to generate 1.42 times less return on investment than Quantum Si. But when comparing it to its historical volatility, Reviva Pharmaceuticals Holdings is 1.06 times less risky than Quantum Si. It trades about 0.05 of its potential returns per unit of risk. Quantum Si incorporated is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  58.00  in Quantum Si incorporated on October 24, 2024 and sell it today you would earn a total of  46.00  from holding Quantum Si incorporated or generate 79.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	92.31%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Quantum Si incorporated

Reviva Pharmaceuticals

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Quantum Si incorporated

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Si incorporated are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quantum Si showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Reviva Pharmaceuticals and Quantum Si

The main advantage of trading using opposite Reviva Pharmaceuticals and Quantum Si positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Quantum Si can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Si will offset losses from the drop in Quantum Si's long position.

The idea behind Reviva Pharmaceuticals Holdings and Quantum Si incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.